Waiving a Patient's Copay, Coinsurance, or Deductible

The authority everyone cites is an HHS Office of Inspector General Special Fraud Alert on the routine waiver of copayments and deductibles under Medicare Part B — issued in the early 1990s and republished in the Federal Register in 1994. Its conclusion is blunt: routinely waiving deductibles and copayments by a provider, practitioner, or supplier paid on the basis of charges is unlawful because it results in false claims, violations of the Anti-Kickback Statute, and excessive use of items and services the program pays for. Those are three separate legal problems from one practice, and it helps to take them one at a time.

The claim misstates the actual charge

A coinsurance or deductible is the patient's slice of a charge, and a charge-based program pays its share of that same charge — the patient is expected to pay the rest. When a practice represents a charge to the program but never actually collects the patient's portion, the amount it truly charges is lower than the amount it reported. The program's payment, keyed to the higher represented figure, is therefore larger than it should be, and the claim that carried that figure misstated it. OIG's point is not that the discount itself is the crime; it is that the claim became false the moment the represented charge stopped matching the charge the practice was really willing to accept.

The waiver can be an inducement

The second problem is that forgiving a patient's obligation for a reason other than that patient's genuine financial hardship can unlawfully induce the patient to buy items or services from the practice. Free care is a powerful draw, and steering a beneficiary's choice with something of value is exactly what the fraud-and-abuse laws police. That makes a routine waiver a potential Anti-Kickback Statute problem and — because the remuneration flows to the patient rather than to a referral source — a matter for a distinct penalty aimed squarely at inducing beneficiaries, covered in the next section.

It drives use that is not needed

The third ground is about behavior. OIG's view is that when patients bear even a small part of a cost, they choose services because they are needed rather than because they are free, and that removing that check tends to increase use of program-paid care. A practice does not usually think of a copay waiver as a utilization problem, but it is the reason the government treats cost-sharing as a feature of the benefit rather than an optional formality a provider is free to erase.

Beyond the Anti-Kickback Statute, there is a civil penalty written specifically for remuneration offered to patients. The Civil Monetary Penalties Law at 42 U.S.C. § 1320a-7a(a)(5) reaches anyone who offers or transfers remuneration to a Medicare or state-health-care-program beneficiary that the person “knows or should know is likely to influence” the beneficiary to order or receive items or services from a particular provider, practitioner, or supplier. This is the beneficiary inducement prohibition, and it is why waiving cost-sharing is not just an Anti-Kickback question.

What makes it bite here is the statute's own definition of remuneration. It expressly “includes the waiver of coinsurance and deductible amounts (or any part thereof), and transfers of items or services for free or for other than fair market value.” A forgiven copay is not on the edge of what counts as remuneration — it is named in the definition. So a standing practice of waiving cost-sharing is remuneration offered to the beneficiary, and the only question left is whether the practice knows or should know it is likely to influence where the patient goes for care.

The exposure is civil rather than criminal, but it is real: monetary penalties per wrongful act and, like the other fraud-and-abuse laws, the possibility of exclusion from the federal programs. And because the same waiver can be framed as an inducement under the Anti-Kickback Statute and as a false claim, one routine practice can draw more than one theory of liability at once.

None of this means a practice must chase a genuinely destitute patient for a copay. The law carves out room for real hardship, and the carve-out is specific. The same statute that names cost-sharing waivers as remuneration excludes from that definition a waiver of coinsurance and deductible amounts where three things are all true: the waiver is not offered as part of any advertisement or solicitation; the practice does not routinely waive cost-sharing; and the practice either waives after determining in good faith that the individual is in financial need, or fails to collect after making reasonable collection efforts.

OIG's own guidance frames the same exception as “non-routine, unadvertised waivers of copayments or deductible amounts based on individualized determinations of financial need or exhaustion of reasonable collection efforts.” The operative word is individualized. A waiver granted to a particular patient after looking at that patient's circumstances is the exception; a policy applied to everyone, or to a whole class, is not — and OIG has been explicit that there is no exemption for categorical financial need, pointing out that Medicaid itself, a program for the financially needy, is squarely within the prohibition.

Because the exception requires that a waiver never be advertised, the marketing side is where a compliant practice most often trips. OIG's alert lists specific promotional claims as indicators of an improper waiver, and they are worth recognizing verbatim in spirit even though the exact wording varies from ad to ad.

• Advertising that “Medicare is accepted as payment in full,” “insurance is accepted as payment in full,” or that there is “no out-of-pocket expense” — each tells beneficiaries their cost-sharing will not be collected.
• Promising “discounts” to Medicare beneficiaries as a class, rather than deciding relief patient by patient.
• Collecting cost-sharing only from patients who happen to carry supplemental (“Medigap”) coverage, so that care is effectively free to everyone else.
• Charging Medicare beneficiaries more than other patients for the same service, so a higher charge quietly offsets the waived share.
• Sham “insurance” plans whose token premium is not based on actuarial risk but exists to disguise a routine waiver.

The common thread is that each turns a case-by-case hardship judgment into a standing offer. A practice can be entirely well-meaning and still land on this list if its front-office scripts, its website, or its intake forms promise patients that their share will not be collected. Reviewing that patient-facing language is a concrete, low-cost control a billing and front-office team owns directly.

The beneficiary-inducement penalty and the routine-waiver alert are federal-program rules — they turn on Medicare, Medicaid, and other government programs. That does not make waiving a commercial insurer's copay a safe habit; it makes it a different question. A commercial plan sets the patient's cost-sharing as part of the benefit it sold, and the provider agreement almost always obligates the practice to collect it. Routinely waiving it can breach that contract, and, as with the government programs, it can misstate the charge the practice represents to the plan.

One more boundary worth naming: forgiving a balance a patient genuinely cannot pay, after real collection efforts, is a bad-debt write-off — an accounting outcome the law contemplates. What the routine-waiver rules forbid is deciding up front never to collect, which is a policy, not an outcome. Keeping the two straight in the practice's own procedures is most of the compliance work.

The waiver rules are one of the few fraud-and-abuse exposures a front-office and billing team controls almost entirely on its own — the practice decides whether to bill the patient's share, and it decides what its ads and scripts say. That makes a short, followed policy the whole game.

1. 01

   Make collecting cost-sharing the default

   Bill and attempt to collect the copayment, coinsurance, and deductible on federal-program claims as the standard practice. The exception is for the patient who cannot pay, decided individually — not a starting posture of forgiveness that a hardship label is applied to after the fact.
2. 02

   Put the hardship exception in writing, and make it individualized

   Adopt a written policy that a waiver requires a good-faith, documented determination of a particular patient's financial need, or a record that reasonable collection efforts failed. Decide it case by case, keep the record, and do not let a blanket form stand in for the judgment.
3. 03

   Scrub the patient-facing language

   Check advertisements, the website, intake forms, and front-desk scripts for any promise that insurance will be “accepted as payment in full” or that there is “no out-of-pocket cost.” That language is on OIG's list of red flags, and it converts an otherwise-defensible hardship practice into an advertised routine waiver.
4. 04

   Route the hard cases, do not improvise them

   A recurring pattern — a referral source whose patients are always waived, a proposed “membership” that covers copays, a marketing idea built on free care — belongs with the compliance program and counsel, not the billing desk. The Anti-Kickback Statute has a safe harbor for waiving beneficiary cost-sharing in defined situations, and whether an arrangement fits it is a legal call, not a front-office one.

Screening is the quiet backstop. Because a waiver-driven inducement can end in exclusion, the same exclusion screening a practice runs on its people and vendors is part of keeping an excluded party off its claims — one more place the controls reinforce each other. A practice that collects cost-sharing by default, waives only on a documented individual basis, and says nothing to the contrary in its marketing has answered the waiver question before an auditor asks it.